{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Malignancies&page=10", "query": { "condition": "Malignancies", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 50308, "total_pages": 5031, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Malignancies&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Malignancies&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T22:44:26.762Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02867007", "title": "KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumor", "Cancer", "Carcinoma" ], "interventions": [ { "name": "KHK2455", "type": "DRUG" }, { "name": "Mogamulizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kyowa Kirin, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2016-08", "completion_date": "2019-12-15", "has_results": false, "last_update_posted_date": "2024-04-25", "last_synced_at": "2026-10-21T22:44:26.762Z", "location_count": 3, "location_summary": "Tampa, Florida • Albuquerque, New Mexico • Houston, Texas", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Albuquerque", "state": "New Mexico" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02867007" }, { "nct_id": "NCT00767936", "title": "Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Liver Cancer", "Hepatitis B", "Hepatitis C", "Hepatobiliary Cancers Liver", "Hepatobiliary Cancers" ], "interventions": [], "intervention_types": [], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 135, "start_date": "2008-03", "completion_date": "2013-09", "has_results": false, "last_update_posted_date": "2016-06-29", "last_synced_at": "2026-10-21T22:44:26.762Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00767936" }, { "nct_id": "NCT00072436", "title": "Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "gemcitabine hydrochloride", "type": "DRUG" }, { "name": "alvocidib", "type": "DRUG" }, { "name": "pharmacological study", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2003-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-07-02", "last_synced_at": "2026-10-21T22:44:26.762Z", "location_count": 3, "location_summary": "Boston, Massachusetts • New York, New York", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00072436" }, { "nct_id": "NCT01685411", "title": "Busulfan and Cyclophosphamide Followed By ALLO BMT", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Myelodysplastic Syndrome" ], "interventions": [ { "name": "Allopurinol", "type": "DRUG" }, { "name": "Keppra", "type": "DRUG" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Mycophenolate mofetil", "type": "DRUG" }, { "name": "Allogeneic hematopoietic stem cell transplant", "type": "BIOLOGICAL" }, { "name": "Filgrastim", "type": "BIOLOGICAL" }, { "name": "antithymocyte globulin", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "44 Years", "sex": "ALL", "summary": "Up to 44 Years" }, "enrollment_count": 5, "start_date": "2013-01", "completion_date": "2020-02-10", "has_results": true, "last_update_posted_date": "2021-04-13", "last_synced_at": "2026-10-21T22:44:26.762Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01685411" }, { "nct_id": "NCT00741871", "title": "A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lymphoma, Malignant", "Hodgkin's Lymphoma", "B Cell Lymphoma" ], "interventions": [ { "name": "SB1518", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "S*BIO", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2008-07", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2012-04-20", "last_synced_at": "2026-10-21T22:44:26.762Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00741871" }, { "nct_id": "NCT00250809", "title": "Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Other Female Genital", "Cancer" ], "interventions": [ { "name": "Placement of a central venous catheter", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 15, "start_date": "1994-03", "completion_date": "2006-03", "has_results": false, "last_update_posted_date": "2024-01-12", "last_synced_at": "2026-10-21T22:44:26.762Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT00250809" }, { "nct_id": "NCT06097832", "title": "Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Light Chain (AL) Amyloidosis" ], "interventions": [ { "name": "NXC-201 CAR-T", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Nexcella Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 45, "start_date": "2024-06-05", "completion_date": "2039-01", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-21T22:44:26.762Z", "location_count": 18, "location_summary": "Berkeley, California • Duarte, California • Los Angeles, California + 14 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06097832" }, { "nct_id": "NCT04090398", "title": "Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anatomic Stage IV Breast Cancer AJCC v8", "Metastatic HER2-Negative Breast Carcinoma", "Metastatic Malignant Neoplasm in the Bone" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Scan", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Electronic Health Record Review", "type": "OTHER" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Radium Ra 223 Dichloride", "type": "RADIATION" }, { "name": "Single Photon Emission Computed Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "OTHER", "DRUG", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2020-08-04", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-21T22:44:26.762Z", "location_count": 30, "location_summary": "Birmingham, Alabama • Duarte, California • Orange, California + 26 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Coral Gables", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04090398" }, { "nct_id": "NCT07220863", "title": "Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer Awareness" ], "interventions": [], "intervention_types": [], "sponsor": "Feminai", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "25 Years to 75 Years · Female only" }, "enrollment_count": 300, "start_date": "2025-10-05", "completion_date": "2026-09-05", "has_results": false, "last_update_posted_date": "2025-10-24", "last_synced_at": "2026-10-21T22:44:26.762Z", "location_count": 1, "location_summary": "Frisco, Texas", "locations": [ { "city": "Frisco", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07220863" }, { "nct_id": "NCT04115163", "title": "Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Pancreatic Adenocarcinoma", "Stage IV Pancreatic Cancer AJCC v8" ], "interventions": [ { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Nab-paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Anne Noonan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 67, "start_date": "2020-06-24", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-10-21T22:44:26.762Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04115163" } ] }